Membership Committee

Chair: Peter Greenleaf, Chief Executive Officer, Sucampo Pharmaceuticals, Inc. 
Staff Contacts:  Frederick Bittenbender, Executive Vice President, Public Affairs,

Description:  The committee provides strategic oversight of membership-related issues, offering guidance and recommendations on various activities, including but not limited to, dues structure (potential dues increases and/or restructuring); the development of a strategic membership plan; and the enhancement of member services and related resources.

Peter Greenleaf, Chief Executive Officer, Sucampo Pharmaceuticals, Inc.

Ron Cohen, President & CEO, Acorda Therapeutics,  Inc.
Paul Hastings, President & CEO, OncoMed Pharmaceuticals, Inc.
Hervé Hoppenot, President & CEO, Incyte Corporation
Robert Kiss, Portfolio Manager, JP Morgan Asset Management
John Maraganore, Chief Executive Officer,  Alnylam Pharmaceuticals  Inc.
Steven Mento, President & CEO, Co-Founder and Chairman, Conatus Pharmaceuticals,  Inc.
John Orwin, Chief Executive Officer, Relypsa,  Inc.
Kristine Peterson, Chief Executive Officer, Valeritas,  Inc.
David Pyott, President & CEO, Allergan, Inc.
Timothy Rodell, President & CEO, GlobeImmune,  Inc.
Ronald Stotish, Chief Executive Officer, Aqua Bounty Technologies, Inc.
Daniel  Tassé, Chairman & CEO, Ikaria, Inc.
Timothy Walbert, Chairman, President & CEO, Horizon Pharma, Inc.

Hide Date: 
Hide Date
Hide Add This: 
Hide Add This